This is the authors' abstract. We don't add key points for this paper.
ORIGINAL ARTICLE, p 1114 Actinic keratoses represent a significant and increasing burden on healthcare systems in many parts of the world. For such a common problem, significant uncertainties still exist over their management. It is generally accepted that a number of actinic keratoses may progress to squamous cell carcinoma,1 but incontrovertible evidence that their treatment reduces the risk is lacking. Nevertheless, there is a widely held belief among many clinicians that treatment of individual actinic keratoses is worthwhile for risk prevention or simply because many of these lesions are symptomatic or of cosmetic concern. Several treatment guidelines list both cryotherapy and the carbon dioxide laser among treatment options,2 3 although evidence of efficacy for the latter has been scarce to date.4 In this issue of BJD, Zane et al.5 provide us with a welcome addition to the comparative data on lesion‐directed treatments for actinic keratoses. In a randomized comparison of cryotherapy and carbon dioxide laser ablation, they demonstrated overall equivalent lesion clearance rates at 3 months of 78·2% and 72·4%, respectively, although thicker lesions responded significantly better to cryotherapy at this time point (cryotherapy 80·2%, laser treatment 59·8%). However, at 12 months, of the lesions apparently clear at 3 months, significantly fewer remained clear in the carbon dioxide laser arm (37%) than with cryotherapy (66·8%).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
R.A. SHEEHAN-DARE (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: